CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells-Reference-Cited by-同舟云学术

CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells

Published:2016-09 Issue:9 Volume:24 Page:1561-1569
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Hoban Megan D,Lumaquin Dianne,Kuo Caroline Y,Romero Zulema,Long Joseph,Ho Michelle,Young Courtney S,Mojadidi Michelle,Fitz-Gibbon Sorel,Cooper Aaron R,Lill Georgia R,Urbinati Fabrizia,Campo-Fernandez Beatriz,Bjurstrom Carmen F,Pellegrini Matteo,Hollis Roger P,Kohn Donald B

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference38 articles.

1. Advances in targeted genome editing;Perez-Pinera;Curr Opin Chem Biol,2012

2. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering;Gaj;Trends Biotechnol,2013

3. Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases;Szczepek;Nat Biotechnol,2007

4. Genome engineering using the CRISPR-Cas9 system;Ran;Nat Protoc,2013

5. Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells;Hoban;Blood,2015

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances and applications of the CRISPR-Cas system in the gene therapy of blood disorders;Gene;2024-12

2. Innovations in Sickle Cell Care: Navigating the Dynamic Treatment Landscape;Current Practices in Sickle Cell Disease;2024-07-26

3. Role of gene therapy in sickle cell disease;Disease-a-Month;2024-07

4. Revolutionising healing: Gene Editing's breakthrough against sickle cell disease;Blood Reviews;2024-05

5. In situ correction of various β-thalassemia mutations in human hematopoietic stem cells;Frontiers in Cell and Developmental Biology;2024-01-25